Ekso Bionics Inc.

0.39
0.01 (3.17%)
At close: Apr 15, 2025, 3:57 PM
0.39
-1.52%
After-hours: Apr 15, 2025, 07:35 PM EDT

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally.

The company operates in two segments, EksoHealth and EksoWorks.

The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms.

Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation.

The company was incorporated in 2005 and is headquartered in Richmond, California.

Ekso Bionics Inc.
Ekso Bionics  Inc. logo
Country United States
IPO Date Jan 17, 2014
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 61
CEO Scott G. Davis

Contact Details

Address:
1414 Harbour Way South
Richmond, California
United States
Website https://www.eksobionics.com

Stock Details

Ticker Symbol EKSO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001549084
CUSIP Number 282644301
ISIN Number US2826443010
Employer ID 00-0000000
SIC Code 3569

Key Executives

Name Position
Scott G. Davis Chief Executive Officer & Director
Jason C. Jones Chief Operating Officer
Jerome Wong Chief Financial Officer & Corporate Secretary
Ann Cookson Human Resources Director
Foon Lim Chwee President of APAC
Katherine Strausser Principal Controls Engineer
Rachael Anderson Global Director of Marketing & Strategic Growth
Stephan Aderhold Senior Vice President & GM of EMEA

Latest SEC Filings

Date Type Title
Apr 10, 2025 S-3 Filing
Apr 10, 2025 DEF 14A Filing
Mar 31, 2025 PRE 14A Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 17, 2025 8-K Current Report
Mar 03, 2025 S-8 Filing
Mar 03, 2025 10-K Annual Report
Mar 03, 2025 8-K Current Report